Analgesics (Pharmacies) - Dominican Republic

  • Dominican Republic
  • Revenue in the Analgesics market is projected to reach US$117.50m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 8.74%, resulting in a market volume of US$164.30m by 2028.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$10.28 are generated in 2024.

Key regions: Europe, United States, Canada, India, South Korea

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Dominican Republic has been experiencing steady growth in recent years.

Customer preferences:
Customers in Dominican Republic have shown a growing preference for analgesics purchased from pharmacies. This can be attributed to several factors. Firstly, pharmacies are seen as reliable sources of medication, providing customers with the assurance of quality and safety. Additionally, pharmacies often offer a wide range of analgesic products, allowing customers to choose the most suitable option for their needs. Lastly, the convenience of purchasing analgesics from pharmacies, which are easily accessible in both urban and rural areas, has also contributed to the preference for this distribution channel.

Trends in the market:
One of the key trends in the Analgesics (Pharmacies) market in Dominican Republic is the increasing demand for over-the-counter (OTC) analgesics. This trend can be attributed to the rising awareness among consumers about self-care and the availability of OTC analgesics for common ailments such as headaches and muscle pain. The convenience and cost-effectiveness of OTC analgesics have also contributed to their popularity. Another trend in the market is the growing demand for natural and herbal analgesics. This trend reflects the global shift towards natural and organic products, driven by increasing health consciousness among consumers. Natural analgesics are perceived as safer and more gentle on the body compared to their synthetic counterparts. This trend is likely to continue as consumers become more aware of the potential side effects of synthetic analgesics.

Local special circumstances:
The Analgesics (Pharmacies) market in Dominican Republic is influenced by several local special circumstances. One such circumstance is the high prevalence of chronic pain conditions in the country. This has led to a higher demand for analgesics, both prescription and OTC, as individuals seek relief from their symptoms. Additionally, the high population density in urban areas has contributed to the growth of the market. Urban dwellers often lead busy and stressful lifestyles, which can result in various types of pain. The easy availability of analgesics in pharmacies has made them a convenient solution for urban residents seeking immediate relief.

Underlying macroeconomic factors:
The growth of the Analgesics (Pharmacies) market in Dominican Republic can be attributed to several underlying macroeconomic factors. Firstly, the country has experienced steady economic growth in recent years, resulting in an increase in disposable income. This has allowed consumers to spend more on healthcare products, including analgesics. Furthermore, the government's focus on improving healthcare infrastructure and access to medication has also contributed to the growth of the market. The expansion of pharmacies in both urban and rural areas has made analgesics more accessible to a larger population. In conclusion, the Analgesics (Pharmacies) market in Dominican Republic is developing due to customer preferences for pharmacy channels, the increasing demand for OTC and natural analgesics, local special circumstances such as the high prevalence of chronic pain conditions, and underlying macroeconomic factors such as economic growth and government initiatives.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)